| scholarly article | Q13442814 |
| P2093 | author name string | Sarah Galbraith | |
| Susan Bray | |||
| Lesley Christie | |||
| Stewart Fleming | |||
| Sharon King | |||
| P2860 | cites work | Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study | Q46647721 |
| Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations | Q48396942 | ||
| Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. | Q54119033 | ||
| Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. | Q55397198 | ||
| Prevalence of ras gene mutations in human colorectal cancers | Q59088716 | ||
| High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas | Q69506614 | ||
| The impact of genetics on the classification of renal carcinoma | Q70567817 | ||
| Spontaneous development of malignant phase hypertension in transgenic Ren-2 rats | Q72118265 | ||
| K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer | Q80136633 | ||
| Renal cell carcinoma and arterial hypertension | Q83274928 | ||
| Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma | Q24337664 | ||
| Absence of ras family point mutations at codons 12, 13 and 61 in N-ethyl-N-hydroxyethylnitrosamine- or N-nitrosomorpholine-induced renal cell tumors in rats | Q28317226 | ||
| Rational siRNA design for RNA interference | Q29614450 | ||
| Captopril restores transforming growth factor-beta type II receptor and sensitivity to transforming growth factor-beta in murine renal cell cancer cells | Q31931162 | ||
| Is cancer related to hypertension or to its treatment? | Q33697736 | ||
| Renal cancer genetics: von Hippel Lindau and other syndromes | Q33759957 | ||
| Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. | Q33843488 | ||
| Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma | Q34320299 | ||
| New ideas about aldosterone signaling in epithelia | Q34552939 | ||
| Contemporary epidemiology of renal cell cancer | Q34598015 | ||
| The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. | Q34696613 | ||
| Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? | Q34749837 | ||
| While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. | Q34989253 | ||
| Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice | Q35108463 | ||
| Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer | Q36200399 | ||
| Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas. | Q36643591 | ||
| Human Colon Carcinoma Ki-ras2 Oncogene and Its Corresponding Proto-Oncogene | Q36946669 | ||
| Epidemiology of kidney cancer | Q36968943 | ||
| An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies | Q37030432 | ||
| Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling | Q38304283 | ||
| Aldosterone induces myofibroblast EGF secretion to regulate epithelial colonic permeability | Q39184355 | ||
| Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma | Q40409431 | ||
| Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma | Q41053553 | ||
| Point mutation at codon 12 of the Ki-ras gene in a primary breast carcinoma and the MDA-MB-134 human mammary carcinoma cell line | Q41733713 | ||
| Infrequent ras oncogene point mutations in renal cell carcinoma | Q41748786 | ||
| Receptor tyrosine kinases mediate epithelial Na(+) channel inhibition by epidermal growth factor | Q42468468 | ||
| Mutations of the VHL tumour suppressor gene in renal carcinoma | Q42806703 | ||
| Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene | Q43066526 | ||
| Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease | Q43670943 | ||
| Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling | Q44185650 | ||
| Regulation of Na+ transport by aldosterone: signaling convergence and cross talk between the PI3-K and MAPK1/2 cascades | Q44811028 | ||
| Ras activates the epithelial Na(+) channel through phosphoinositide 3-OH kinase signaling | Q44950440 | ||
| Mutations in the ras protooncogenes are rare events in renal cell cancer | Q44993791 | ||
| Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas | Q45345804 | ||
| Ras couples phosphoinositide 3-OH kinase to the epithelial Na+ channel | Q46490014 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 244-250 | |
| P577 | publication date | 2014-05-07 | |
| P1433 | published in | International Journal of Experimental Pathology | Q15750807 |
| P1476 | title | Evidence for aldosterone-dependent growth of renal cell carcinoma | |
| P478 | volume | 95 |
| Q58544609 | Association of Papillary Thyroid Carcinoma with Primary Aldosteronism |
| Q27340035 | GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells |
| Q42153567 | Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear function |
| Q90219809 | Primary Aldosteronism Associated with Multiple Adrenocortical Micronodules in a Patient with Renal Cell Carcinoma |
| Q55003080 | Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines. |
Search more.